Neurologist Claims There Is No
Such Thing as ADHD
by Robert Wilde 11 Mar 2014, 11:56 AM PDT
Dr. Richard Saul, a behavioral neurologist
based in Chicago, has made an interesting observation about the squirming,
unfocused children brought to his office by desperate parents who beg him to
ease their child’s ADHD behavior. After 50 years of practicing medicine and seeing
thousands of patients demonstrating symptoms of Attention Deficit Hyperactivity
Disorder, Dr Saul’s observation is that: ADHD doesn’t exist.
More than ten percent of American children
have been diagnosed with the disorder, and it is now considered the most common
mental health disorder in the United
Kingdom. Unfortunately, the drug that has
been most often prescribed for the condition, Ritalin,
which was designed to stimulate the brain and reduce fidgeting, proves to
sometimes exacerbate the condition and creates its own matrix of side effects,
including dangerous behavior. According to Dr. Saul, treating so called ADHD behavior with
stimulants is neglectful and wrong.
In the 70s, Saul believed in ADHD;
however, he has come to the conclusion that an array of childhood attention
disorders may be rooted in nutritional deficiencies. In many situations, iron
deficiency (otherwise known as anemia) can produce fatigue, poor attention and
concentration, and memory problems. Once iron was added to the diet with iron
pills and more fish, fruit, vegetables, and nuts, performance and behavior
improved. Significantly, a 2004 French study discovered that 84% of children
diagnosed with ADHD were iron deficient, compared to only 18% of children that
were not diagnosed with the alleged disease.
Dr. Saul has identified up to twenty
diseases that have been misdiagnosed as ADHD, including Tourette syndrome,
obsessive compulsive disorder, and schizophrenia. He believes that people who
think they have ADHD or some other condition
are dealing with a normal level of stress in a faster-paced world. The doctor
recommends that changing your lifestyle, eating better, getting exercise, and
sleeping more will mitigate the symptoms normally associated with ADHD.
Methylphenidate (Ritalin)
Methylphenidate (trade names Concerta,
Methylin, Ritalin, Equasym XL) is a
psychostimulant drug and substituted phenethylamine approved for treatment of
attention-deficit hyperactivity disorder (ADHD), postural orthostatic
tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now
Novartis Corporation. It was first
licensed by the U.S. Food and Drug Administration
(FDA) in 1955 for treating what was then known as hyperactivity. Prescribed to
patients beginning in 1960, the drug became heavily prescribed in the 1990s,
when the diagnosis of ADHD itself became more widely accepted.
Novartis Corporation
Novartis
Corporation is a U.S.
subsidiary of Novartis AG, and a member of the Pharmaceutical Research and Manufacturers of America.
Note: Akin,
Gump, Strauss, Hauer & Feld, LLP is the lobby firm for the Novartis Corporation, and the Pharmaceutical
Research and Manufacturers of America.
James F.
Collins was a senior advisor for Akin, Gump, Strauss, Hauer
& Feld, LLP, and is a senior associate at the Carnegie Endowment for International Peace (think tank).
William
W. George is a trustee at the Carnegie Endowment for
International Peace (think tank), and was a director at Novartis AG.
Daniel
Vasella was the chairman for Novartis AG,
and is a trustee at the Carnegie Endowment for
International Peace (think tank).
Carnegie
Endowment for International Peace (think tank)
was a funder for the Nuclear Threat Initiative
(think tank).
Margaret
A. Hamburg is a VP for the Nuclear Threat Initiative
(think tank), and the commissioner for the U.S. Food
and Drug Administration (FDA).
Jessica Tuchman Mathews
is a director at the Nuclear Threat Initiative
(think tank), the president of the Carnegie
Endowment for International Peace (think tank), a director at the
American Friends of Bilderberg
(think tank), was an honorary trustee at the Brookings
Institution (think tank), and a 2008 Bilderberg conference participant (think tank).
Ed Griffin’s interview
with Norman Dodd in 1982
(The investigation into
the Carnegie Endowment for International Peace uncovered the plans for
population control by involving the United States in war)
Foundation
to Promote Open Society was a funder for the Carnegie Endowment for International Peace (think tank), and the
Brookings Institution (think tank).
George Soros
was the chairman for the Foundation to
Promote Open Society.
Donald
Kennedy was a trustee at the Carnegie
Endowment for International Peace (think tank), and a commissioner
for the U.S. Food and Drug Administration (FDA).
Mark
B. McClellan was a senior fellow at the Brookings
Institution (think tank), and a commissioner for the U.S. Food and Drug Administration (FDA).
Ann M. Fudge
is a trustee at the Brookings Institution (think
tank), and a director at Novartis AG.
Marjorie
M.T. Yang is a director at Novartis AG,
and was a trustee at the Conference Board.
Klaus Kleinfeld is a
trustee at the Brookings Institution (think
tank), a trustee at the Conference Board (think
tank), a director at Bayer AG, and a
2008 Bilderberg conference
participant (think tank).
Bayer AG
The Bayer company then became part of IG
Farben, a German chemical company conglomerate. During World War II, the IG
Farben used slave labor in factories attached to large slave labor camps,
notably the sub-camps of the Mauthausen-Gusen concentration camp.[3] IG Farben
owned 42.5% of the company that manufactured Zyklon B,[4] a chemical used in
the gas chambers of Auschwitz and other extermination camps. After World War
II, the Allies broke up IG Farben and Bayer reappeared as an individual
business. The Bayer executive Fritz ter Meer, sentenced to seven years in
prison during the IG Farben Military Tribunal at Nuremberg, was made head of the supervisory
board of Bayer in 1956, after his release.
Bayer
Corporation is the North American subsidiary of Bayer AG.
Mayer
Brown was the lobby firm for the Bayer Corporation.
William M. Daley
Professional career
Daley returned to the practice of law, as a partner with the
firm Mayer Brown (then Mayer, Brown & Platt) from
1993 to 1997.
William
M. Daley was a partner at Mayer Brown,
the chief of staff for the Barack Obama
administration, and is a member of the Commercial
Club of Chicago.
Robert A.
Helman is a partner at Mayer Brown, a
member of the Commercial Club of Chicago, and
was an honorary trustee at the Brookings
Institution (think tank).
Cyrus
F. Freidheim Jr. is an honorary trustee at the Brookings
Institution (think tank), and a member of the Commercial
Club of Chicago.
Newton N.
Minow is a member of the Commercial Club of Chicago,
and a senior counsel at Sidley Austin LLP.
R. Eden
Martin is the president of the Commercial Club of Chicago,
and counsel at Sidley Austin LLP
Michelle
Obama was a lawyer at Sidley Austin LLP.
Barack Obama
was an intern at Sidley Austin LLP.
Sidley
Austin LLP is the lobby firm for Bayer HealthCare.
Bayer
HealthCare is a subsidiary of Bayer AG.
No comments:
Post a Comment